Accordingly, in another model of pancreatic cancer, DAPT restrained the effects caused by DLL4-induced Notch activation, and pre-treatment with a high dose of DAPT abrogated DLL4/Notch-induced chemoresistance led to the activation of apoptosis and reduced the CSC pool [581]. The gene discussed is DLL4; the disease is familial pancreatic carcinoma.